Syndax Pharmaceuticals, Inc

(NASDAQ:SNDX)

Latest On Syndax Pharmaceuticals, Inc (SNDX):

Date/Time Type Description Signal Details
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.59 beats by $0.01N/A
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 02:38 ESTNewsSyndax Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-03-04 02:40 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 16:35 ESTNewsSyndax Pharmaceuticals: 2023 Is A Pivotal YearN/A
2023-03-01 01:25 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04N/A
2023-02-27 19:50 ESTNewsSyndax Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-01-12 14:22 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2022-12-17 03:56 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at 64th ASH Annual Meeting & ExpositionN/A
2022-12-12 19:48 ESTNewsKura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidatesN/A
2022-12-10 16:27 ESTNewsSyndax Pharmaceuticals: Today's Best Nearby Biotech Cap-Gain ProspectN/A
2022-12-07 20:58 ESTNewsSyndax Pharmaceuticals prices $150M offeringN/A
2022-12-07 01:27 ESTNewsSyndax Pharma to sell $150M stock in public offeringN/A
2022-12-05 14:27 ESTNewsSyndax receives breakthrough therapy tag for revumenib to treat acute leukemiaN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q3 2022 Earnings Call TranscriptN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-04 08:33 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.58 beats by $0.07; updates FY22 guidanceN/A
2022-11-02 23:19 ESTNewsSyndax Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62N/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 07:37 ESTNewsSyndax Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-13 12:56 ESTNewsKeith Goldan joins Syndax Pharmaceuticals as CFON/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 16:51 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.63N/A
2022-05-09 00:26 ESTNewsSyndax Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-08 05:11 ESTNewsSyndax Pharmaceuticals: Cash-Rich With 2 Promising DrugsN/A
2022-03-25 00:25 ESTNewsSyndax Pharmaceuticals (SNDX) Presents At Barclays Global Healthcare ConferenceN/A
2022-03-02 06:49 ESTNewsSyndax appoints former Alnylam executive as new medical chiefN/A
2022-03-02 06:49 ESTNewsSyndax Pharmaceuticals GAAP EPS of $1.81 beats by $1.84, revenue of $126.6M beats by $67.92MN/A
2022-03-02 06:48 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 18:56 ESTNewsSyndax Pharmaceuticals Q4 Earnings PreviewN/A
2022-01-29 06:36 ESTNewsSyndax Pharmaceuticals (SNDX) Investor Presentation - SlideshowN/A
2021-12-23 00:22 ESTNewsSyndax's SNDX-5613 an Orphan Drug in Europe for acute myeloid leukemiaN/A
2021-12-16 14:02 ESTNewsSyndax Pharma raises $75M via stock offeringN/A
2021-12-15 18:28 ESTNewsSyndax Pharmaceuticals drops 6% following underwritten stock offeringN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals EPS misses by $0.35, misses on revenueN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-14 18:13 ESTNewsSyndax Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-11-04 16:35 ESTNewsSyndax Pharma falls after updating early-stage data for leukemia therapyN/A
2021-10-05 15:59 ESTNewsSyndax Pharma CFO Daphne Karydas to resign to pursue another opportunityN/A
2021-09-28 02:06 ESTNewsIncyte and Syndax in pact for xatilimab targeting immune-related conditionsN/A
2021-08-10 12:01 ESTNewsSyndax Pharmaceuticals EPS beats by $0.28, beats on revenueN/A
2021-08-10 12:00 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 11:59 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-07-22 02:04 ESTNewsSyndax Pharmaceuticals: Updated Analysis After Reporting Interim Phase 1 DataN/A
2021-07-22 02:02 ESTNewsCanopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst actionN/A
2021-07-22 01:35 ESTNewsSyndax shares rise on FDA Fast Track status for leukemia treatment SNDX-5613N/A

About Syndax Pharmaceuticals, Inc (SNDX):

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Syndax Pharmaceuticals, Inc
  • Symbol SNDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Fiscal Year EndDecember
  • IPO Date2016-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.syndax.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 634.74
  • Price/Book (Most Recent Quarter) 4.43
  • Enterprise Value Revenue 542.55
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.19
  • Next Year EPS Estimate -$2.17
  • Next Quarter EPS Estimate -$0.47
  • Operating Margin -4708%
  • Return on Assets -25%
  • Return on Equity -52%
  • Revenue 1.52 million
  • Earnings Per Share -$2.36
  • Revenue Per Share $0.04
  • Gross Profit 1.52 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.16 billion
  • EBITDA -67280000
  • PE Ratio -125.39
  • Analyst Target Price $32.14
  • Book Value Per Share $5.27
View More

Share Statistics

  • Shares Outstanding 48.24 million
  • Shares Float 42.95 million
  • % Held by Insiders 645%
  • % Held by Institutions 78.88%
  • Shares Short 4.93 million
  • Shares Short Prior Month 4.93 million
  • Short Ratio 9.27
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.84
  • 52 Week High $27.12
  • 52 Week Low $8.18
  • 50 Day Moving Average 22.33
  • 200 Day Moving Average 20.55
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Syndax Pharmaceuticals, Inc (SNDX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Syndax Pharmaceuticals, Inc (SNDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-08$380000-$0.44-$0.5113.23%
2020-09-302020-11-02$N/A-$0.46-$0.43-6.75%
2020-06-302020-08-06$N/A-$0.42-$0.444.76%
2020-03-312020-05-07$379000-$0.56-$0.53-6.65%
2019-12-312020-03-03$380000-$0.44-$0.43-1.31%
2019-09-302019-11-07$379000-$0.41-$0.4813.92%
2019-06-302019-08-07$379000-$0.47-$0.470.76%
2019-03-312019-05-06$379000-$0.53-$0.554.14%
2018-12-312019-03-07$379000-$0.70-$0.64-9.43%
2018-09-302018-11-05$379000-$0.68-$0.7610.21%
2018-06-302018-08-07$379000-$0.74-$0.8916.94%
2018-03-312018-05-08$379000-$0.79-$0.9517.15%
2017-12-312018-03-05$1.19 million-$0.80-$0.77-3.67%
2017-09-302017-11-07$305000-$0.68-$0.8216.63%
2017-06-302017-08-10$305000-$0.70-$0.8214.83%
2017-03-312017-05-08$305000-$0.71-$0.710.56%
2016-12-312017-03-02$305000-$0.59-$0.7419.79%
2016-09-302016-11-10$305000-$0.84-$0.82-2.78%
2016-06-302016-08-09$305000-$0.47-$0.5412.18%
2016-03-312016-05-16$305000-$0.73-$0.48-52.22%

Syndax Pharmaceuticals, Inc (SNDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Syndax Pharmaceuticals, Inc (SNDX) Chart:

Syndax Pharmaceuticals, Inc (SNDX) News:

Below you will find a list of latest news for Syndax Pharmaceuticals, Inc (SNDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Syndax Pharmaceuticals, Inc (SNDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-04-1710CALL0 0643.12TRUE00
2026-04-1720CALL0 0485.37TRUE00
2026-04-1730CALL0 00TRUE00
2026-04-1740CALL0 00TRUE00
2026-04-1750CALL0 00TRUE00
2026-04-1760CALL0 00TRUE00
2026-04-1777.8CALL0 1232.88TRUE00
2026-04-1780CALL0 0238.94TRUE00
2026-04-1790CALL0 0249.25TRUE00
2026-04-171014.2CALL0 408237.17TRUE00
2026-04-171110.4CALL0 60TRUE00
2026-04-171210.16CALL0 9193.83TRUE00
2026-04-17138.5CALL0 88174.87TRUE00
2026-04-171410.11CALL0 14102.81TRUE00
2026-04-171510.3CALL0 359140.94TRUE00
2026-04-17168.2CALL0 432118TRUE00
2026-04-17178.5CALL0 15695.94TRUE00
2026-04-17186.5CALL0 11690.78TRUE00
2026-04-17195.99CALL0 49131.72TRUE00
2026-04-17205.4CALL10 139105.26TRUE5.40
2026-04-17213.5CALL0 4862.6TRUE00
2026-04-17223.2CALL0 6795.8TRUE00
2026-04-17232.3CALL0 9560.28TRUE00
2026-04-17241.9CALL0 5756.31TRUE00
2026-04-17251.62CALL38 234071.66FALSE0.470.41
2026-04-17261.25CALL62 7672.85FALSE1.250
2026-04-17270.75CALL31 3364.62FALSE-0.4-0.35
2026-04-17280.6CALL10 160868.71FALSE0.60
2026-04-17290.4CALL2 1767.45FALSE0.40
2026-04-17300.25CALL3 18165.71FALSE0.010.04
2026-04-17310CALL0 0162.47FALSE00
2026-04-17321.2CALL0 1126.87FALSE00
2026-04-17330CALL0 0180.91FALSE00
2026-04-17341.05CALL0 1180.11FALSE00
2026-04-17350.15CALL26 7488.52FALSE0.020.15
2026-04-1710PUT0 00FALSE00
2026-04-1720PUT0 00FALSE00
2026-04-1730PUT0 00FALSE00
2026-04-1740PUT0 00FALSE00
2026-04-1750PUT0 00FALSE00
2026-04-1760PUT0 01323.11FALSE00
2026-04-1770PUT0 0741.62FALSE00
2026-04-1780PUT0 0424.52FALSE00
2026-04-1790PUT0 0356.34FALSE00
2026-04-17100.05PUT3 333179.76FALSE0.050
2026-04-17110.9PUT0 43294.51FALSE00
2026-04-17120.03PUT0 16385.46FALSE00
2026-04-17131.4PUT0 63348.69FALSE00
2026-04-17140.55PUT0 111240.48FALSE00
2026-04-17151.1PUT0 26218.29FALSE00
2026-04-17160.5PUT0 312197.46FALSE00
2026-04-17170.75PUT0 56177.75FALSE00
2026-04-17181.6PUT0 15158.97FALSE00
2026-04-17190.19PUT0 864127.72FALSE00
2026-04-17202PUT0 35120.43FALSE00
2026-04-17210.55PUT0 16103.53FALSE00
2026-04-17220.65PUT0 164278.94FALSE00
2026-04-17230.75PUT3 15362.64FALSE0.750
2026-04-17240PUT0 058.46FALSE00
2026-04-17251.7PUT0 1156.39TRUE00
2026-04-17260PUT0 048.24TRUE00
2026-04-17270PUT0 069.26TRUE00
2026-04-17280PUT0 081.06TRUE00
2026-04-17290PUT0 067.46TRUE00
2026-04-17300PUT0 072.86TRUE00
2026-04-17310PUT0 080.83TRUE00
2026-04-17320PUT0 075.55TRUE00
2026-04-17330PUT0 082.08TRUE00
2026-04-17340PUT0 097.96TRUE00
2026-04-17350PUT0 088.11TRUE00
2026-05-15159.2CALL0 599.39TRUE00
2026-05-15160CALL0 092.61TRUE00
2026-05-15170CALL0 085.57TRUE00
2026-05-15180CALL0 081.28TRUE00
2026-05-15190CALL0 080.89TRUE00
2026-05-15200CALL0 072.24TRUE00
2026-05-15210CALL0 078.23TRUE00
2026-05-15220CALL0 085.71TRUE00
2026-05-15230CALL0 071.02TRUE00
2026-05-15240CALL0 070.41TRUE00
2026-05-15253.06CALL0 1074.3FALSE00
2026-05-15262.5CALL102 881.98FALSE0.550.28
2026-05-15270CALL0 072.42FALSE00
2026-05-15280CALL0 070.3FALSE00
2026-05-15290CALL0 070.41FALSE00
2026-05-15300CALL0 071.65FALSE00
2026-05-15310.85CALL0 168.29FALSE00
2026-05-15320CALL0 0101.41FALSE00
2026-05-15350CALL0 0178.16FALSE00
2026-05-15150PUT0 0186.9FALSE00
2026-05-15160PUT0 0170.38FALSE00
2026-05-15170PUT0 0200.33FALSE00
2026-05-15180PUT0 0155.93FALSE00
2026-05-15190PUT0 0114.38FALSE00
2026-05-15200PUT0 073.28FALSE00
2026-05-15210PUT0 072.05FALSE00
2026-05-15221.8PUT0 270.69FALSE00
2026-05-15230PUT0 072.11FALSE00
2026-05-15240PUT0 070.11FALSE00
2026-05-15250PUT0 068.57TRUE00
2026-05-15260PUT0 066.74TRUE00
2026-05-15270PUT0 067.43TRUE00
2026-05-15280PUT0 067.32TRUE00
2026-05-15290PUT0 076.45TRUE00
2026-05-15300PUT0 069.16TRUE00
2026-05-15310PUT0 058.21TRUE00
2026-05-15320PUT0 073.81TRUE00
2026-05-15350PUT0 066.03TRUE00
2026-07-1750CALL0 0189.71TRUE00
2026-07-1790CALL0 0106.43TRUE00
2026-07-17100CALL0 094.86TRUE00
2026-07-17110CALL0 084.47TRUE00
2026-07-171211CALL0 353.78TRUE00
2026-07-17130CALL0 066.39TRUE00
2026-07-17140CALL0 063.7TRUE00
2026-07-171510CALL0 780.15TRUE00
2026-07-17160CALL0 067.17TRUE00
2026-07-17170CALL0 071.35TRUE00
2026-07-17187.98CALL0 9869.76TRUE00
2026-07-17190CALL0 068.69TRUE00
2026-07-17205.9CALL0 967.92TRUE00
2026-07-17214.77CALL0 769.58TRUE00
2026-07-17223.5CALL0 1263.72TRUE00
2026-07-17234.17CALL0 671.47TRUE00
2026-07-17244.5CALL0 20767.21TRUE00
2026-07-17252.41CALL0 6769.38FALSE00
2026-07-17262.5CALL0 7670.27FALSE00
2026-07-17270CALL0 075.02FALSE00
2026-07-17280CALL0 071.4FALSE00
2026-07-17291.66CALL0 270.84FALSE00
2026-07-17301.85CALL0 8468.76FALSE00
2026-07-17311.7CALL0 197.64FALSE00
2026-07-17321.3CALL0 1124.06FALSE00
2026-07-17331.05CALL0 4131.93FALSE00
2026-07-17340CALL0 0132.28FALSE00
2026-07-17351.55CALL0 2112.09FALSE00
2026-07-1750PUT0 0375.37FALSE00
2026-07-1790PUT0 0215.24FALSE00
2026-07-17100PUT0 0207.67FALSE00
2026-07-17110PUT0 0170.06FALSE00
2026-07-17120PUT0 0181.39FALSE00
2026-07-17130PUT0 0166.27FALSE00
2026-07-17140PUT0 0165.74FALSE00
2026-07-17150PUT0 0131.77FALSE00
2026-07-17161.6PUT0 1139.48FALSE00
2026-07-17171.75PUT0 5128.99FALSE00
2026-07-17182.1PUT0 8108.69FALSE00
2026-07-17192.75PUT0 33120.26FALSE00
2026-07-17200PUT0 076.31FALSE00
2026-07-17213.7PUT0 1282.95FALSE00
2026-07-17220PUT0 066.65FALSE00
2026-07-17233.2PUT0 171.42FALSE00
2026-07-17245.7PUT0 477.8FALSE00
2026-07-17255.97PUT0 1079.38TRUE00
2026-07-17260PUT0 071.99TRUE00
2026-07-17270PUT0 081.43TRUE00
2026-07-17280PUT0 068.29TRUE00
2026-07-17290PUT0 071.04TRUE00
2026-07-17300PUT0 063.7TRUE00
2026-07-17310PUT0 068.31TRUE00
2026-07-17320PUT0 069.59TRUE00
2026-07-173313.65PUT0 166.14TRUE00
2026-07-17340PUT0 066.4TRUE00
2026-07-17350PUT0 063.7TRUE00
2026-08-21110CALL0 088.38TRUE00
2026-08-21120CALL0 085.6TRUE00
2026-08-21130CALL0 091.49TRUE00
2026-08-21140CALL0 078.33TRUE00
2026-08-21150CALL0 072.3TRUE00
2026-08-21160CALL0 076.5TRUE00
2026-08-21170CALL0 072.88TRUE00
2026-08-21180CALL0 075.26TRUE00
2026-08-21190CALL0 074TRUE00
2026-08-21200CALL0 072.1TRUE00
2026-08-21210CALL0 073.53TRUE00
2026-08-21220CALL0 073.16TRUE00
2026-08-21230CALL0 078.26TRUE00
2026-08-21240CALL0 073.14TRUE00
2026-08-21250CALL0 079.24FALSE00
2026-08-21264.22CALL0 187.07FALSE00
2026-08-21273.9CALL0 180.61FALSE00
2026-08-21280CALL0 065.88FALSE00
2026-08-21290CALL0 077.87FALSE00
2026-08-21300CALL0 076.32FALSE00
2026-08-21310CALL0 066.14FALSE00
2026-08-21320CALL0 063.96FALSE00
2026-08-21350CALL0 073.83FALSE00
2026-08-21110PUT0 0173.67FALSE00
2026-08-21120PUT0 0146.97FALSE00
2026-08-21130PUT0 0153.65FALSE00
2026-08-21140PUT0 0145.37FALSE00
2026-08-21150PUT0 0130.77FALSE00
2026-08-21160PUT0 0131.24FALSE00
2026-08-21170PUT0 0123.9FALSE00
2026-08-21180PUT0 0122.34FALSE00
2026-08-21190PUT0 0116.16FALSE00
2026-08-21200PUT0 067.69FALSE00
2026-08-21210PUT0 087.33FALSE00
2026-08-21223PUT0 1172.89FALSE00
2026-08-21230PUT0 069.93FALSE00
2026-08-21240PUT0 075.34FALSE00
2026-08-21250PUT0 074.16TRUE00
2026-08-21260PUT0 074.91TRUE00
2026-08-21270PUT0 071.15TRUE00
2026-08-21280PUT0 073.33TRUE00
2026-08-21290PUT0 069.45TRUE00
2026-08-21300PUT0 069.13TRUE00
2026-08-21310PUT0 070.04TRUE00
2026-08-21320PUT0 068.04TRUE00
2026-08-21350PUT0 070.23TRUE00
2026-09-18110CALL0 085.69TRUE00
2026-09-18120CALL0 073.88TRUE00
2026-09-18130CALL0 078.47TRUE00
2026-09-18140CALL0 068.4TRUE00
2026-09-18150CALL0 072.06TRUE00
2026-09-18160CALL0 067.67TRUE00
2026-09-18170CALL0 071.05TRUE00
2026-09-18180CALL0 072.73TRUE00
2026-09-18190CALL0 068.18TRUE00
2026-09-18200CALL0 071.15TRUE00
2026-09-18210CALL0 072.14TRUE00
2026-09-18220CALL0 072.4TRUE00
2026-09-18235.93CALL0 870.47TRUE00
2026-09-18240CALL0 072.79TRUE00
2026-09-18254.65CALL10 1067.7FALSE-0.05-0.01
2026-09-18260CALL0 081.68FALSE00
2026-09-18270CALL0 061.79FALSE00
2026-09-18280CALL0 060.77FALSE00
2026-09-18290CALL0 059.31FALSE00
2026-09-18300CALL0 063.36FALSE00
2026-09-18310CALL0 061.1FALSE00
2026-09-18320CALL0 063.03FALSE00
2026-09-18350CALL0 071.06FALSE00
2026-09-18110PUT0 0247.94FALSE00
2026-09-18120PUT0 0226.69FALSE00
2026-09-18130PUT0 0142.72FALSE00
2026-09-18140PUT0 0120.29FALSE00
2026-09-18150PUT0 0152.21FALSE00
2026-09-18160PUT0 0144.83FALSE00
2026-09-18170PUT0 0107.52FALSE00
2026-09-18180PUT0 0110.58FALSE00
2026-09-18192.4PUT0 195.38FALSE00
2026-09-18200PUT0 0114.21FALSE00
2026-09-18210PUT0 061.61FALSE00
2026-09-18220PUT0 069.35FALSE00
2026-09-18230PUT0 057.4FALSE00
2026-09-18240PUT0 069.58FALSE00
2026-09-18250PUT0 081.39TRUE00
2026-09-18260PUT0 067.01TRUE00
2026-09-18270PUT0 059.22TRUE00
2026-09-18280PUT0 067.12TRUE00
2026-09-18290PUT0 059.89TRUE00
2026-09-18300PUT0 068.56TRUE00
2026-09-18310PUT0 069.5TRUE00
2026-09-18320PUT0 068.61TRUE00
2026-09-18350PUT0 071.18TRUE00
2026-10-16110CALL0 077.89TRUE00
2026-10-16120CALL0 077.28TRUE00
2026-10-16130CALL0 077.5TRUE00
2026-10-16140CALL0 074.86TRUE00
2026-10-16157.4CALL0 2077.51TRUE00
2026-10-16160CALL0 078.58TRUE00
2026-10-16170CALL0 074.25TRUE00
2026-10-16180CALL0 072.94TRUE00
2026-10-16190CALL0 075.79TRUE00
2026-10-16200CALL0 075.89TRUE00
2026-10-16210CALL0 072.16TRUE00
2026-10-16220CALL0 075.28TRUE00
2026-10-16230CALL0 071.67TRUE00
2026-10-16240CALL0 075.84TRUE00
2026-10-16255.17CALL0 1873.71FALSE00
2026-10-16260CALL0 071.98FALSE00
2026-10-16270CALL0 074.07FALSE00
2026-10-16280CALL0 073.06FALSE00
2026-10-16290CALL0 072.08FALSE00
2026-10-16300CALL0 073.54FALSE00
2026-10-16310CALL0 072.68FALSE00
2026-10-16320CALL0 068.78FALSE00
2026-10-16350CALL0 072.63FALSE00
2026-10-16110PUT0 0182.94FALSE00
2026-10-16120PUT0 0164.83FALSE00
2026-10-16130PUT0 0154.06FALSE00
2026-10-16140PUT0 0151.49FALSE00
2026-10-16152.27PUT0 5119.06FALSE00
2026-10-16160PUT0 0111.51FALSE00
2026-10-16173.04PUT0 5122.42FALSE00
2026-10-16180PUT0 0112.63FALSE00
2026-10-16190PUT0 0101.6FALSE00
2026-10-16200PUT0 071.5FALSE00
2026-10-16210PUT0 070.33FALSE00
2026-10-16223.75PUT0 10076.48FALSE00
2026-10-16230PUT0 073.07FALSE00
2026-10-16240PUT0 074.86FALSE00
2026-10-16250PUT0 074.01TRUE00
2026-10-16260PUT0 073.17TRUE00
2026-10-16270PUT0 071.29TRUE00
2026-10-16280PUT0 071.14TRUE00
2026-10-16290PUT0 067.25TRUE00
2026-10-16300PUT0 067.81TRUE00
2026-10-16310PUT0 068.06TRUE00
2026-10-16320PUT0 069.43TRUE00
2026-10-16350PUT0 068.5TRUE00
2027-01-1530CALL0 0146.56TRUE00
2027-01-1550CALL0 0103.12TRUE00
2027-01-15812.8CALL0 1795.58TRUE00
2027-01-151011CALL0 4480.59TRUE00
2027-01-151312.7CALL0 14173.52TRUE00
2027-01-151511.5CALL0 17081.69TRUE00
2027-01-151710.3CALL0 1784.67TRUE00
2027-01-15209.88CALL0 13077.5TRUE00
2027-01-15227.73CALL0 342280.35TRUE00
2027-01-15256.79CALL0 4279.36FALSE00
2027-01-15275.75CALL0 6877.95FALSE00
2027-01-15305.09CALL0 4180.65FALSE00
2027-01-15320CALL0 078.8FALSE00
2027-01-15352.6CALL0 1475.88FALSE00
2027-01-15370CALL0 076.27FALSE00
2027-01-15404.06CALL0 13876.29FALSE00
2027-01-1530PUT0 00FALSE00
2027-01-1550PUT0 00FALSE00
2027-01-1580PUT0 0275.67FALSE00
2027-01-15100PUT0 0219.39FALSE00
2027-01-15133.7PUT0 5167.22FALSE00
2027-01-15154.45PUT0 15142.22FALSE00
2027-01-15170PUT0 0121.54FALSE00
2027-01-15204.25PUT0 177.3FALSE00
2027-01-15220PUT0 077.13FALSE00
2027-01-15258.5PUT0 10477.19TRUE00
2027-01-15270PUT0 076.89TRUE00
2027-01-153011.5PUT0 8973.41TRUE00
2027-01-15320PUT0 074.49TRUE00
2027-01-15350PUT0 075.14TRUE00
2027-01-15370PUT0 075.2TRUE00
2027-01-154020.89PUT0 775.56TRUE00
2028-01-21317.61CALL0 185.81TRUE00
2028-01-2150CALL0 090.89TRUE00
2028-01-2180CALL0 090.06TRUE00
2028-01-211016.3CALL0 3982.64TRUE00
2028-01-21136CALL0 180.51TRUE00
2028-01-21150CALL0 076.73TRUE00
2028-01-21179.05CALL0 2778.6TRUE00
2028-01-212011.57CALL0 10177.95TRUE00
2028-01-21228.5CALL0 377.55TRUE00
2028-01-212511.1CALL6 384.8FALSE11.10
2028-01-212710CALL10 079.92FALSE100
2028-01-21306.98CALL0 10277.96FALSE00
2028-01-21320CALL0 077.69FALSE00
2028-01-21355.78CALL0 677.19FALSE00
2028-01-21377.25CALL10 075.94FALSE7.250
2028-01-21406CALL7 370.53FALSE60
2028-01-2130PUT0 00FALSE00
2028-01-2150PUT0 00FALSE00
2028-01-2180PUT0 0189.39FALSE00
2028-01-21102.71PUT0 3150.62FALSE00
2028-01-21132.7PUT0 7195.84FALSE00
2028-01-21153.2PUT0 271.94FALSE00
2028-01-21174.65PUT0 2972.7FALSE00
2028-01-21205.58PUT0 076.88FALSE00
2028-01-21227.35PUT0 275.13FALSE00
2028-01-21259.3PUT6 078.76TRUE9.30
2028-01-21270PUT0 074.16TRUE00
2028-01-213013.6PUT0 074.67TRUE00
2028-01-21320PUT0 073.1TRUE00
2028-01-21350PUT0 071.2TRUE00
2028-01-21370PUT0 072.82TRUE00
2028-01-214021.92PUT0 2973.76TRUE00

Latest SNDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST3$15.6
Jun 13, 2022 7:59 PM EST4$15.6
Jun 13, 2022 7:59 PM EST1$15.6
Jun 13, 2022 7:59 PM EST100$15.61
Jun 13, 2022 7:59 PM EST45$15.61

Syndax Pharmaceuticals, Inc (SNDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2019-09-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1395937/000000000019013216/0000000000-19-013216-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000021545719006549/0000215457-19-006549-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720006818/0000834237-20-006818-index.htm
2020-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720010194/0000834237-20-010194-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221919000254/0000902219-19-000254-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221920000308/0000902219-20-000308-index.htm
2019-04-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266419001816/0000902664-19-001816-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266420000971/0000902664-20-000971-index.htm
2020-11-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000091957420006675/0000919574-20-006675-index.htm
2018-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518001976/0000921895-18-001976-index.htm
2018-11-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518003173/0000921895-18-003173-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189519000467/0000921895-19-000467-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189520000574/0000921895-20-000574-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359419000160/0001013594-19-000160-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359420000127/0001013594-20-000127-index.htm
2018-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018005/0001140361-18-018005-index.htm
2018-04-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018007/0001140361-18-018007-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312518197997/0001193125-18-197997-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519034379/0001193125-19-034379-index.htm
2019-03-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519088951/0001193125-19-088951-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312519092679/0001193125-19-092679-index.htm
2019-03-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519092701/0001193125-19-092701-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1395937/000119312519235283/0001193125-19-235283-index.htm
2019-09-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1395937/000119312519239953/0001193125-19-239953-index.htm
2019-09-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519242045/0001193125-19-242045-index.htm
2019-10-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519265254/0001193125-19-265254-index.htm
2020-02-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312520022917/0001193125-20-022917-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312520023646/0001193125-20-023646-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520037637/0001193125-20-037637-index.htm
2020-05-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520139263/0001193125-20-139263-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002680/0001562180-18-002680-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002681/0001562180-18-002681-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002682/0001562180-18-002682-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002683/0001562180-18-002683-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002684/0001562180-18-002684-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002685/0001562180-18-002685-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004047/0001562180-18-004047-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004048/0001562180-18-004048-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004049/0001562180-18-004049-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004050/0001562180-18-004050-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000852/0001562180-19-000852-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000853/0001562180-19-000853-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000854/0001562180-19-000854-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000855/0001562180-19-000855-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000856/0001562180-19-000856-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002023/0001562180-19-002023-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003487/0001562180-19-003487-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003488/0001562180-19-003488-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003489/0001562180-19-003489-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003490/0001562180-19-003490-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003491/0001562180-19-003491-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003492/0001562180-19-003492-index.htm
2019-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003880/0001562180-19-003880-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001228/0001562180-20-001228-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001229/0001562180-20-001229-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001230/0001562180-20-001230-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001231/0001562180-20-001231-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001232/0001562180-20-001232-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001233/0001562180-20-001233-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001234/0001562180-20-001234-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001235/0001562180-20-001235-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001236/0001562180-20-001236-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001237/0001562180-20-001237-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005102/0001562180-20-005102-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2018-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018004520/0001564590-18-004520-index.htm
2018-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459018004911/0001564590-18-004911-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018011784/0001564590-18-011784-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018012378/0001564590-18-012378-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018014349/0001564590-18-014349-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018019907/0001564590-18-019907-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018020483/0001564590-18-020483-index.htm
2018-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459018020504/0001564590-18-020504-index.htm
2018-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018023593/0001564590-18-023593-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018026817/0001564590-18-026817-index.htm
2018-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018026892/0001564590-18-026892-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019002676/0001564590-19-002676-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019006772/0001564590-19-006772-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019006777/0001564590-19-006777-index.htm
2019-03-1810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019008313/0001564590-19-008313-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019014263/0001564590-19-014263-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019015972/0001564590-19-015972-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019017318/0001564590-19-017318-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019022241/0001564590-19-022241-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019024625/0001564590-19-024625-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030050/0001564590-19-030050-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019030067/0001564590-19-030067-index.htm
2019-08-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030084/0001564590-19-030084-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019036518/0001564590-19-036518-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019041712/0001564590-19-041712-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019041719/0001564590-19-041719-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019045581/0001564590-19-045581-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020004037/0001564590-20-004037-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020005551/0001564590-20-005551-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020008426/0001564590-20-008426-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459020009016/0001564590-20-009016-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019694/0001564590-20-019694-index.htm
2020-04-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020019928/0001564590-20-019928-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019941/0001564590-20-019941-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020020574/0001564590-20-020574-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020020633/0001564590-20-020633-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020022849/0001564590-20-022849-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020022971/0001564590-20-022971-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020031882/0001564590-20-031882-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037719/0001564590-20-037719-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037767/0001564590-20-037767-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020037777/0001564590-20-037777-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020049638/0001564590-20-049638-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020051287/0001564590-20-051287-index.htm
2019-09-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1395937/999999999519002056/9999999995-19-002056-index.htm
2018-11-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999716026189/9999999997-16-026189-index.htm
2018-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718004150/9999999997-18-004150-index.htm
2018-06-13CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718006372/9999999997-18-006372-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718007508/9999999997-18-007508-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718009113/9999999997-18-009113-index.htm
2019-03-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999719002097/9999999997-19-002097-index.htm

Syndax Pharmaceuticals, Inc (SNDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syndax Pharmaceuticals, Inc (SNDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 645%
Institutional Ownership: 7888%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-04-03Peter OrdentlichChief Scientific OfficerSell7,500.0015.00112,500.000.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2020-07-06Michael L. MeyersSVP, Chief Medical OfficerBuy3,500.0010,730.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-11-04Michael A MetzgerPresident and COOBuy100,000.007.20720,000.00117,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-09Briggs MorrisonChief Executive OfficerBuy13,200.007.5699,726.0013,200.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2020-02-12Michael A MetzgerPresident and COOBuy15,000.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-11-04Michael A MetzgerPresident and COOSell100,000.0020.312,031,410.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-13Briggs MorrisonChief Executive OfficerBuy7,200.007.2952,516.8020,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2018-10-30Michael L. MeyersSVP, Chief Medical OfficerBuy200.004.79958.002,398.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-10-10Briggs MorrisonChief Executive OfficerBuy11,000.005.4059,400.0031,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-04Briggs MorrisonChief Executive OfficerBuy12,500.008.00100,000.0043,900.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy1,000.004.934,930.007,118.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy104.004.87506.487,222.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2018-04-03Peter OrdentlichChief Scientific OfficerBuy7,500.003.0823,100.007,500.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm